Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

The Rule 8.3 report published earlier today showed incorrect data regarding open positions in the Supplemental Form. This has been corrected. FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 25 June 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,127,519 2.70% 90,941 0.12% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 120,500 0.15% 53,600 0.07% agreements to purchase/sell Total 2,248,019 2.85% 144,541 0.18% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 1,700 35.79676471 Purchase 10 35.5667 Purchase 400 35.72 Purchase 1,000 35.73704 Purchase 100 35.07 Purchase 300 35.86666667 Purchase 7,500 35.5912 Purchase 200 35.64 Purchase 1,800 35.4 Purchase 956 35.74627615 Purchase 200 35.3625 Purchase 100 35.53 Purchase 100 35.7 Purchase 300 35.54 Purchase 100 35.51 Purchase 1,007 35.60109732 Purchase 3,900 35.5592 Purchase 9,500 35.5592 Purchase 3,376 35.7929295 Purchase 5,500 35.5592 Purchase 100 35.5592 Purchase 10 35.5592 Purchase 25 35.9000 USD Purchase 200 35.866 Purchase 147 35.9000 USD Purchase 126 35.9000 USD Purchase 68 35.9000 USD Purchase 44 35.9000 USD Purchase 1,861 35.65752284 Purchase 22 35.9000 USD Purchase 21 35.9000 USD Purchase 21 35.9000 USD Purchase 100 35.86 Purchase 811 35.69421702 Purchase 2 35.9 Purchase 1,215 35.73030453 Purchase 400 35.72 Purchase 1,457 35.78165408 Purchase 158 35.20253165 Purchase 1,000 35.737 Sale 700 35.52785714 Sale 1,100 35.58454545 Sale 2,700 35.58518519 Sale 1,000 35.62 Sale 400 35.7925 Sale 700 35.60285714 Sale 200 35.64 Sale 100 35.66 Sale 144 35.9 Sale 1,900 35.58737895 Sale 100 35.53 Sale 627 35.58733652 Sale 1,779 35.59907813 Sale 91 35.66318681 Sale 180 35.64444444 Sale 7,055 35.70440454 Sale 5 35.5592 Sale 29 35.65 Sale 200 35.635 Sale 1,007 35.60109732 Sale 1,800 35.4 Sale 389 35.9 Sale 900 35.73555556 Sale 900 35.3954 USD Sale 500 35.3954 USD Sale 99 35.9000 USD Sale 53 35.9000 USD Sale 100 35.842 Sale 100 35.89 Sale 611 35.89036007 Sale 9,400 35.5592 Sale 100 35.5592 Sale 300 35.6033 Sale 100 35.75 Sale 158 35.20253165 Sale 400 35.72 Sale 5 35.5592 Sale 200 35.3625 Sale 5,200 35.6451 USD Sale 700 35.76714286 Sale 1,100 35.85254545 Sale 200 35.66 Sale 376 35.75300532 Sale 200 35.84 Sale 1,500 35.77066667 Sale 600 35.65583333 Sale 3,277 35.57329875 Sale 300 35.74 Sale 859 35.5798603 Sale 559 35.9 Sale 300 35.86666667 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 26 June 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased 100 35.0000 AMER 22/08/2009 Option Purchased 100 25.0000 AMER 20/02/2010 Option Purchased 100 15.0000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -23,900 25.0000 AMER 22/08/2009 Option Purchased -600 30.0000 AMER 21/11/2009 Option Purchased 700 30.0000 AMER 22/08/2009 Option Purchased -900 30.0000 AMER 18/07/2009 Option Purchased -1,200 30.0000 AMER 22/01/2011 Option Purchased -2,000 40.0000 AMER 18/07/2009 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -2,400 25.0000 AMER 16/01/2010 Option Purchased -2,900 35.0000 AMER 18/07/2009 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -11,100 30.0000 AMER 18/07/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 22,300 25.0000 AMER 22/08/2009 Option Purchased 8,300 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 5,800 40.0000 AMER 22/08/2009 Option Purchased 4,400 35.0000 AMER 16/01/2010 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased 3,100 35.0000 AMER 21/11/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 2,500 45.0000 AMER 21/11/2009 Option Purchased 500 35.0000 AMER 18/07/2009 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 1,600 30.0000 AMER 22/08/2009 Option Purchased 1,400 40.0000 AMER 21/11/2009 Option Purchased 1,100 30.0000 AMER 21/11/2009 Option Purchased 1,000 55.0000 AMER 22/01/2011 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 900 22.5000 AMER 22/08/2009 Option Purchased 700 35.0000 AMER 16/01/2010 Option Purchased 40,000 35.0000 AMER 22/08/2009 Option Purchased 2,700 50.0000 AMER 16/01/2010 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings